ICLR vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 17, 2026

ICLR

59.1
AI Score
VS
ICLR Wins

MEDP

58.2
AI Score

Investment Advisor Scores

ICLR

59score
Recommendation
HOLD

MEDP

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ICLR MEDP Winner
Revenue 2.03B 706.60M ICLR
Net Income 104.75M 123.87M MEDP
Net Margin 5.2% 17.5% MEDP
Operating Income 173.73M 141.50M ICLR
ROE 1.1% 20.7% MEDP
ROA 0.6% 5.8% MEDP
Total Assets 16.32B 2.13B ICLR
Cash 765.16M 652.68M ICLR
Current Ratio 1.14 0.85 ICLR
Free Cash Flow 136.24M 144.97M MEDP

Relative Price Performance (Last 90 Days)

ICLR 1M: -8.4% · 3M: +40.5% MEDP 1M: +3.0% · 3M: +37.5%

Current Technical Phase

ICLR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 44.4 · Price: $158.54

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.0% over 20 days), RSI 60

RSI (14): 60.2 · Price: $574.32

Fundamentals Snapshot

Metric ICLR MEDP
Market Cap
Forward P/E 13.8 32.3
Trailing P/E 78.8 33.4
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 0.3% 0.7%
Operating Margin 0.1% 0.2%
EPS 2.10 15.79
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICLR is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.